Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combinations

Vaccine

Volumn 21, Issue 9-10, 2003, Pages 877-882

  Büchler, Tomas ^a   Hajek, Roman ^a,b   Bourkova, Lida ^a   Kovarova, Lucie ^a   Musilova, Romana ^a   Bulikova, Alena ^a   Doubek, Michal ^a   Svobodnik, Adam ^b   Mareschova, Iveta ^a,b   Vanova, Pavlina ^a   Tuzova, Eva ^a   Vidlakova, Petra ^a   Vorlicek, Jiri ^a   Penka, Miroslav ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Cytokines; Dendritic cells; Immunotherapy; In vitro cell culture

Indexed keywords

CD40 LIGAND; CD83 ANTIGEN; CELL MARKER; CYTOKINE; FLT3 LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; PROSTAGLANDIN E1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APHERESIS; CELL ACTIVATION; CELL COUNT; CELL CULTURE; CELL LINE; CELL MATURATION; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MONONUCLEAR CELL; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL MOBILIZATION; VENOUS BLOOD;

ANTIGENS; CANCER VACCINES; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; CYTOKINES; DENDRITIC CELLS; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY; INTERLEUKIN-12; INTERLEUKIN-4; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037435979     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00535-2     Document Type: Conference Paper

References (26)

1. Steinman R.M. Dendritic cells and immune-based therapies. Exp. Hematol. 24(8):1996;859-862.
2. Hajek R., Butch A.W. Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma. Med. Oncol. 17(1):2000;2-15.
3. Lardon F., Snoeck H.W., Berneman Z.N.et al. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor. Immunology. 91(4):1997;553-559.
4. Szabolcs P., Avigan D., Gezelter S.et al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood. 87(11):1996;4520-4530.
5. Caux C., Vanbervliet B., Massacrier C.et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF-alpha. J. Exp. Med. 184(2):1996;695-706.
6. Bender A., Sapp M., Schuler G., Steinman R.M., Bhardwaj N. Improved methods for the generation of dendritic cells from non-proliferating progenitors in human blood. J. Immunol. Methods. 196(2):1996;121-135.
7. Romani N., Reider D., Heuer M.et al. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J. Immunol. Methods. 196(2):1996;137-151.
8. Bernhard H., Disis M.L., Heimfeld S., Hand S., Gralow J.R., Cheever M.A. Generation of immuno-stimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res. 55(5):1995;1099-1104.
9. Herbst B., Kohler G., Mackensen A., Veelken H., Mertelsmann R., Lindemann A. CD34+ peripheral blood progenitor cell and monocyte derived dendritic cells: a comparative analysis. Br. J. Haematol. 99(3):1997;490-499.
10. Chapuis F., Rosenzwajg M., Yagello M., Ekman M., Biberfeld P., Gluckman J.C. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 27(2):1997;431-441.
11. Galy A., Morel F., Hill B., Chen B.P. Hematopoietic progenitor cells of lymphocytes and dendritic cells. J. Immunother. 21(2):1998;132-141.
12. Hart D.N.J. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 90(9):1997;3245-3287.
13. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products. J. Exp. Med. 182(2):1995;389-400.
14. O'Doherty U., Peng M., Gezelter S.et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology. 82(3):1994;487-493.
15. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392(6673):1998;245-252.
16. Syme R., Glück S. Effect of cytokines on the culture and differentiation of dendritic cells in vitro. J. Hematother. Stem Cell Res. 10(1):2001;43-51.
17. Yang S., Darrow T.L., Vervaert C.E., Seigler H.F. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow. Cell. Immunol. 179(1):1997;84-95.
18. Tarte K., Fiol G., Rossi J.F., Klein B. Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro. Leukemia. 14(12):2000;2182-2192.
19. Reichardt V.L., Okada C.Y., Liso A.et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180(7):1994;83-93.
20. Bohlen H., Thielemanns K., Tesch H.et al. Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bi-specific idiotype × anti-class II antibodies can protect against tumor growth. Cytokines Mol. Ther. 2(4):1996;231.
21. Lim SH, Bailey-Wood R. Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma. Int J Cancer 1999;83(2):215-22.
22. Wen Y.J., Ling M., Bailey-Wood R., Lim S.H. Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma. Clin. Cancer Res. 4(4):1998;957-962.
23. McCarthy D.A., Macey M.G., Bedford P.A., Knight S.C., Dumonde D.C., Brown K.A. Adhesion molecules are up-regulated on dendritic cells isolated from human blood. Immunology. 92(2):1997;244-251.
24. Weissman D., Li Y., Orenstein J.M., Fauci A.S. Both a precursor, and a mature population of dendritics cells can bind HIV: however, only the mature population that expresses CD80 can pass infection to unstimulated CD4+ T cells. J. Immunol. 155(8):1995;4111-4117.
25. Fearnley D.B., Whyte L.F., Carnoutsos S.A., Cook A.H., Hart D.N. Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood. 93(2):1999;728-736.
26. Mosca P.J., Hobeika A.C., Clay T.M.et al. A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment. Blood. 96(10):2000;3499-3504.